The Future of Pancreatic Cancer Treatment: A Deep Dive into Neoadjuvant Therapy
This meta-analysis evaluates the prognostic value of neoadjuvant therapy versus upfront surgery in resectable and borderline resectable pancreatic cancer, revealing significant improvements in R0 resection rates and overall survival.